from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1153c/omt

LFCtreatmentdescriptionclass of inhibitor

0.244

Amikacinug/mL Amikacintranslation

-0.481

Cap5-10ug/mL Capreomycintranslation

0.255

Rox10-50 ug/mL Roxithromycintranslation

-0.209

SM2-5 ug/mL Streptomycintranslation

-1.564

Tet5-10 ug/mL Tetracyclinetranslation

0.642

Rif0.2-5ug/mL Rifampicintranscription

0.462

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.944

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.070

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.145

CPZ10-50 ug/mL Chlorpromazinerespiration

0.572

Clofazimine10-13 ug/mL Clofaziminerespiration

0.756

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.262

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.509

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.808

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.883

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.968

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.271

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.927

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.228

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.066

KCN5-20 ug/mL Potassium cyaniderespiration

-0.365

NaN30.2-2 mM Sodium aziderespiration

0.505

Nigericin50 uM Nigericinrespiration

-0.043

TRC10-150 ug/mL Triclosanrespiration

-0.666

TRZ10-25 ug/mL Thioridazinerespiration

-1.514

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.731

menadione6-10 ug/mL Menadionerespiration

0.064

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.181

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.551

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.009

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.902

NRP_1Non-replicating persistence stage 1dosRassociated

-0.539

Amp0.2mg/mL AmpicillincellWall

0.185

Cephalexin20-100 ug/mL CephalexincellWall

-0.084

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.652

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.039

EMB10-20 ug/mL EthambutolcellWall

-0.112

Eta12-40 ug/mL EthionamidecellWall

0.782

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.005

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.069

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.445

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.415

BZA0.12 mg/mL BenzamidearomaticAmides

0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.153

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.184

H2O24 mM hydrogen peroxideDNAdamaging

0.288

Levo10 ug/mL LevofloxacinDNAdamaging

-0.059

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.030

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.060

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.002

UVUV-irradiationDNAdamaging

0.002

ARP41-4 ug/mL Antitubercular compound ARP4?

1.040

Antimycin12.5-50 ug/mL Antimycin A?

-0.887

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.290

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.041

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.814

PA8240.2-2 ug/mL PA-824?

-0.742

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.426

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.424

Verapamil50 uM Verapamil?

-0.241

mercaptoethanol2 mM 2-Mercaptoethanol?

0.434

methoxatin10-20 ug/mL Methoxatin?